Abiopharma

Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology

Cybin to Participate in the 2025 Psychedelic Science Conference

Avanzanite annuncia la partnership paneuropea con Agios per lanciare mitapivat nelle malattie ematologiche rare

Response to SGX Queries

Novavaxs COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Medtech Industry Establishes Foundation for Clinical Trials with Veeva MedTech

A New Press Release from Oncolytics Biotech, Inc

Moderna - Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program

Pasithea Therapeutics Appoints Expert in ETS2-driven Inflammatory Disease to Scientific Advisory Board